Advanced Breast Cancer - OECI
Advanced Breast Cancer - OECI
Advanced Breast Cancer - OECI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
September-October 2012 Number 50<br />
IT’S FUTILE<br />
So why do we do it,<br />
and how can we stop?<br />
A NEW TOOL<br />
IN THE ARMOURY?<br />
Immunotherapies have never<br />
looked more promising<br />
THE FATAL ALLURE OF<br />
ALTERNATIVE THERAPIES<br />
One woman’s story of how<br />
she lost her chance to be cured<br />
A B C<br />
B r i d g i n g t h e G a p<br />
<strong>Advanced</strong><br />
<strong>Breast</strong> <strong>Cancer</strong><br />
partner journal<br />
7-9 November 2013 Lisbon, Portugal<br />
Second International<br />
Consensus Conference<br />
Conference Chairs:<br />
Fatima Cardoso, PT Eric P. Winer, US Larry Norton, US Alberto Costa, IT/CH<br />
dedicated media partner<br />
<strong>Cancer</strong>World 50 September-October 2012<br />
SECOND ANNOUNCEMENT AND CALL FOR ABSTRACTS<br />
The ABC 2 guidelines will be<br />
developed by ESO and ESMO<br />
The ABC2 conference and guidelines are endorsed by<br />
FEDERACIÓN<br />
LATINOAMERICANA<br />
DE MASTOLOGIA<br />
SOCIÉTÉ<br />
INTERNATIONALE<br />
DE SÉNOLOGIE<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 1<br />
SENOLOGIC<br />
INTERNATIONAL<br />
SOCIETY
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Dear Colleagues,<br />
T<br />
he 1st International Consensus Conference for <strong>Advanced</strong> <strong>Breast</strong><br />
<strong>Cancer</strong> (ABC1), which took place in Lisbon, Portugal in November<br />
2011, brought together 800 participants from 64 countries worldwide<br />
to develop a set of consensus guidelines for the management of<br />
advanced breast cancer (ABC). Participants – including health professionals,<br />
patient advocates and journalists – agreed to a series of guidelines, which<br />
are based on the most up-to-date evidence and can be used to guide<br />
treatment decision making in diverse health care settings globally.<br />
ABC Consensus Conferences have the ambitious goal of improving outcomes<br />
for all patients with advanced breast cancer. We believe that, backed by<br />
strong political advocacy, ABC guidelines will raise standards of care,<br />
improve awareness about how best to meet the needs of this underserved<br />
group of patients, and help identify research priorities so that clinical<br />
research is focused on the most important areas of unmet need.<br />
The guidelines developed at ABC1 have been welcomed by a broad<br />
spectrum of professional and patient organizations active in breast cancer<br />
setting. Discussions are on-going with a number of international oncology<br />
societies regarding the endorsement of the guidelines that will greatly<br />
increase their impact globally.<br />
Furthermore, we are pleased to announce that the ABC2 guidelines will be<br />
developed in co-operation with ESMO and will be endorsed by EUSOMA<br />
FLAM and SIS.<br />
The encouragement and positive feedback we have received from individual<br />
patients and professionals has emphasised the importance of this initiative<br />
and reinforced our belief that this effort is worth pursuing in the long term.<br />
It is therefore with great enthusiasm that we invite you to attend the<br />
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
(ABC2) that will take place in Lisbon, Portugal, on 7-9 November 2013.<br />
ABC2 will have a specific additional program for breast cancer advocates<br />
coordinated by some of the major breast cancer advocacy groups worldwide.<br />
By working together we can change the dismal survival figures associated<br />
with ABC and improve the quality of life of all patients living with ABC<br />
worldwide.<br />
Fatima Cardoso, Eric P. Winer, Larry Norton and Alberto Costa<br />
ABC Conference Chairs<br />
2<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Dates and Team<br />
By 8 July 2013 Abstract submission Submit online at www.abc-lisbon.org<br />
Dolores Knupfer (2)<br />
dknupfer@eso.net<br />
By 19 August 2013<br />
By 21 October 2013<br />
After 21 October 2013<br />
By 31 October 2013<br />
Early registration<br />
Late registration<br />
On-site registration<br />
Accommodation<br />
and<br />
Optional tours<br />
Register online at www.abc-lisbon.org<br />
Laura Richetti (2)<br />
lrichetti@eso.net<br />
Book online at<br />
https://pco.abreu.pt/CLIENTES/abreu/<br />
formularios/form_9638101886.php<br />
Helder Carvalho (3)<br />
hcarvalho.lisboa@abreu.pt<br />
Organisation Roberta Ventura (1)<br />
rventura@eso.net<br />
Programme<br />
Secretariat<br />
Exhibition, satellite<br />
symposia and<br />
sponsorship<br />
Dolores Knupfer (2)<br />
abc@eso.net<br />
Chatrina Melcher (2)<br />
cmelcher@eso.net<br />
Communication Gabriele Maggini (2)<br />
gmaggini@eso.net<br />
1 European School of Oncology<br />
Head Office<br />
Via Turati, 29<br />
20121 Milano, Italy<br />
ph +39 02 85464 532<br />
fx +39 02 85464 545<br />
www.abc-lisbon.org<br />
www.eso.net<br />
2 European School of Oncology<br />
Bellinzona Office<br />
Piazza Indipendenza 2<br />
6500 Bellinzona, Switzerland<br />
ph +41 91 820 0950<br />
fx +41 91 820 0953<br />
www.abc-lisbon.org<br />
www.eso.net<br />
3 Viagens Abreu SA<br />
Av. 25 de Abril, 2<br />
2799-556 Linda-a-Velha, Portugal<br />
ph +351 21 415 6120<br />
fx +351 21 415 6383<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 3
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Official carrier<br />
Star Alliancemembers airlines are pleased to be appointed<br />
as the Official Airline Network for ABC2 – <strong>Advanced</strong> <strong>Breast</strong><br />
<strong>Cancer</strong> Second International Consensus Conference.<br />
T<br />
o obtain the Star Alliance Conventions<br />
Plus discounts and for booking office<br />
information, please visit<br />
www.staralliance.com/conventionsplus and:<br />
1 Choose “For delegates”<br />
2 Under “Delegates login” enter<br />
conventions code TP01S13<br />
3 Choose one of the participating airlines<br />
listed<br />
4 Call the respective reservation contact<br />
listed and quote the convention code<br />
TP01S13 when booking the ticket.<br />
Registered participants plus one<br />
accompanying person travelling to the<br />
event can qualify for a discount of up<br />
to 20%, depending on fare and class of<br />
travel booked.<br />
The participating airlines for ABC2 are:<br />
Adria Airways, Aegean Airlines, Air Canada,<br />
Air China, ANA, Asiana Airlines, Austrian<br />
Airlines, Avianca / TACA, Airlines Blue1,<br />
Brussels Airlines, Croatia Airlines, EgyptAir,<br />
LOT Polish Airlines, Lufthansa, Scandinavian<br />
Airlines, Singapore Airlines, South African<br />
Airways, SWISS International Air Lines,<br />
TAM Airlines, TAP Portugal, THAI, Turkish<br />
Airlines, United, US Airways<br />
Discounts are offered on most published<br />
business and economy class fares, excluding<br />
senior and youth fares, agency and industry<br />
discount, web, bilateral or round the world<br />
fares.<br />
Please note: For travel from Japan and New<br />
Zealand special fares or discounts are offered<br />
by the participating airlines on their own<br />
network.<br />
Agreement states The Conventions Plus Fare<br />
is not applicable for travel to or from New<br />
Zealand and Japan. Special offers for travel<br />
to/from New Zealand and Japan are available.<br />
When making your travel plans please<br />
present confirmation of your registration or<br />
proof of attendance.<br />
4<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
General information<br />
Venue<br />
ABC2 will be held at the CCL - Centro de<br />
Congressos de Lisboa, Praça das Industrias,<br />
Lisbon, Portugal.<br />
Official language<br />
The official language will be English.<br />
No translation will be provided.<br />
Insurance<br />
The organisers bear no responsibility<br />
for untoward events in relation to the<br />
participation in the Conference. Participants<br />
are advised to take out their own personal<br />
and travel insurance coverage.<br />
Abstract book<br />
The abstract book will be published as<br />
a supplement of The <strong>Breast</strong> and contain<br />
abstracts of the invited lecturers and those<br />
submitted by the participants that have been<br />
accepted for oral or poster presentation or for<br />
publication only.<br />
Filming, audio-taping and photographs<br />
Please note that capturing contents of the<br />
sessions is prohibited.<br />
CME accreditation and certificates<br />
Participants will be entitled to receive a<br />
certificate of attendance from Friday,<br />
8 November, by completing the online<br />
evaluation questionnaire.<br />
Application for CME recognition will be<br />
submitted to the European Society for<br />
Medical Oncology<br />
(ESMO) for ESMO-MORA<br />
accreditation, to the<br />
Accreditation Council of<br />
Oncology in Europe (ACOE) and<br />
to the European Accreditation<br />
Council for Continuing Medical<br />
Education (EACCME), an<br />
institution of the European<br />
Union of Medical Specialists<br />
(UEMS).<br />
EACCME credits are recognised by the<br />
American Medical Association towards the<br />
Physician’s Recognition Award (PRA).<br />
Information on the status of the applications<br />
can be obtained from the organising<br />
secretariat.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 5
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
ABC Award<br />
ESO is pleased to announce that, in recognition<br />
of his work on discovering fundamental,<br />
clinically-relevant biological and molecular<br />
mechanisms for metastases including site<br />
specificity, latency, self-seeding and the role<br />
of the microenvironment in colonization and<br />
drug resistance, the first ABC<br />
Award has been assigned to<br />
Joan Massagué.<br />
The Award Ceremony and<br />
Lecture are scheduled on<br />
Thursday, 7 November 2013.<br />
Chairs<br />
Fatima Cardoso<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit,<br />
Champalimaud <strong>Cancer</strong> Center,<br />
Lisbon, PT<br />
Alberto Costa<br />
Scientific Director,<br />
European School of Oncology,<br />
Milan, IT and Bellinzona, CH<br />
Larry Norton<br />
<strong>Breast</strong> <strong>Cancer</strong> Programs,<br />
Memorial Sloan-Kettering<br />
<strong>Cancer</strong> Centre, New York, US<br />
Eric P. Winer<br />
<strong>Breast</strong> Oncology Center,<br />
Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Faculty members<br />
Matti S. Aapro<br />
IMO Clinique De Genolier, Institut<br />
Multidisciplinaire d’Oncologie, Genolier, CH<br />
Fabrice André<br />
Department of Medical Oncology, Gustave Roussy<br />
Institute, Villejuif, FR<br />
Rajendra A. Badwe<br />
Department of Surgical Oncology, Tata Memorial<br />
Hospital, Mumbai, IN<br />
Carlos H. Barrios<br />
Department of Medicine, PUCRS School of<br />
Medicine, Porto Allegre, BR<br />
Jonas Bergh<br />
Department of Oncology-Pathology, Karolinska<br />
Institute, Stockholm, SE<br />
Laura Biganzoli<br />
Department of Medical Oncology, Sandro Pitigliani<br />
Oncology Centre, Prato, IT<br />
6<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Kimberley L. Blackwell<br />
<strong>Breast</strong> <strong>Cancer</strong> Clinical Program, Duke <strong>Cancer</strong><br />
Institute, Durham, US<br />
David A. Cameron<br />
Edinburgh <strong>Breast</strong> Unit, Western General Hospital,<br />
Edinburgh, UK<br />
Maria João Cardoso<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit, Champalimaud <strong>Cancer</strong> Center,<br />
Lisbon, PT<br />
Tanja Cufer<br />
University Clinic of Respiratory & Allergic Diseases<br />
Golnik, Golnik, SL<br />
Nagi S. El Saghir<br />
NK Basile <strong>Cancer</strong> Institute, American University of<br />
Beirut Medical Center, Beirut, LB<br />
Lesley Fallowfield<br />
Sussex Health Outcomes Research & Education<br />
in <strong>Cancer</strong>, Brighton & Sussex Medical School,<br />
University of Sussex, Brighton, UK<br />
Doris Fenech<br />
<strong>Breast</strong> Care Support Group, Europa Donna Malta,<br />
Mtarfa, MT<br />
Prudence A. Francis<br />
Division of <strong>Cancer</strong> Medicine, Peter MacCallum<br />
<strong>Cancer</strong> Centre, Melbourne, AU<br />
Patricia A. Ganz<br />
Department of Health Services, Jonsson<br />
Comprehensive <strong>Cancer</strong> Center, Los Angeles, US<br />
Karen Gelmon<br />
Department of Medical Oncology, BC <strong>Cancer</strong><br />
Agency, Vancouver, CA<br />
Joseph Gligorov<br />
Department of Medical Oncology, <strong>Cancer</strong>Est APHP<br />
Tenon, University Paris VI, Paris, FR<br />
Sharon H. Giordano<br />
Department of <strong>Breast</strong> Medical Oncology, UT MD<br />
Anderson <strong>Cancer</strong> Centre, Houston, US<br />
Nadia Harbeck<br />
<strong>Breast</strong> Center, University of Munich, Munich, DE<br />
Nehmat Houssami<br />
Screening and Test Evaluation Program (STEP),<br />
Sydney Medical School, University of Sydney, AU<br />
Clifford A. Hudis<br />
<strong>Breast</strong> and Imaging Center, Memorial Sloan-<br />
Kettering <strong>Cancer</strong> Centre, New York, US<br />
Bella Kaufman<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit, Sheba Medical Center, Tel<br />
Hashomer, Israel, IL<br />
Ian E. Krop<br />
<strong>Breast</strong> Oncology Center, Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Stella Kyriakides<br />
Europa Donna Cyprus, Nicosia, CY<br />
Nancy U. Lin<br />
<strong>Breast</strong> Oncology Center, Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Joan Massagué<br />
<strong>Cancer</strong> Biology and Genetics Program, Memorial<br />
Sloan-Kettering <strong>Cancer</strong> Center, New York, US<br />
Musa Mayer<br />
<strong>Advanced</strong>BC.org, New York, US<br />
Sofia D. Merajver<br />
University of Michigan Medical School and School of<br />
Public Health, Ann Arbor, US<br />
Anwar R. Padhani<br />
<strong>Cancer</strong> Imaging, Paul Strickland Scanner Centre,<br />
Mount Vernon <strong>Cancer</strong> Centre, Northwood, UK<br />
Olivia Pagani<br />
Department of Medical Oncology, Oncology Institute<br />
of Southern Switzerland, Bellinzona, CH<br />
Frédérique Pernault-Llorca<br />
Jean Perrin Centre, Comprehensive <strong>Cancer</strong> Centre,<br />
Clermont Ferrand, FR<br />
Martine J. Piccart<br />
Department of Medicine, Jules Bordet Institute,<br />
Brussels, BE<br />
Kathy Redmond<br />
<strong>Cancer</strong> World Magazine, Editor, Lugano, CH<br />
Hope S. Rugo<br />
<strong>Breast</strong> Oncology and Clinical Trials Education, UCSF<br />
Helen Diller Family Comprehensive <strong>Cancer</strong> Center,<br />
San Francisco, US<br />
Elzbieta Senkus-Konefka<br />
Department of Oncology and Radiotherapy, Medical<br />
University of Gdansk, Gdansk, PL<br />
George W. Sledge<br />
Division of Oncology, Stanford School of Medicine,<br />
Stanford, US<br />
Christoph Thomssen<br />
Clinic for Gynaecology, Martin-Luther-Universität,<br />
Klinikum Kröllwitz, Halle (Saale), DE<br />
Laura van’t Veer<br />
<strong>Breast</strong> Oncology Program, University of California,<br />
San Francisco, US<br />
Daniel A. Vorobiof<br />
Sandton Oncology Centre, Johannesburg, ZA<br />
Conny Vrieling<br />
Department of Radiotherapy, Eaux Vives Oncology<br />
Centre, Geneva, CH<br />
Nicola West<br />
Nursing Division, Health Board, Cardiff and Vale<br />
University, Cardiff, UK<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 7
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Coordinators:<br />
Fatima Cardoso<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit,<br />
Champalimaud <strong>Cancer</strong> Center,<br />
Lisbon, PT<br />
David A. Cameron<br />
Edinburgh <strong>Breast</strong> Unit, Western General Hospital,<br />
Edinburgh, UK<br />
Alberto Costa<br />
Scientific Director, European School of Oncology,<br />
Milan, IT and Bellinzona, CH<br />
Tanja Cufer<br />
University Clinic of Respiratory & Allergic Diseases<br />
Golnik, Golnik, SL<br />
Lesley Fallowfield<br />
Sussex Health Outcomes Research & Education<br />
in <strong>Cancer</strong>, Brighton & Sussex Medical School,<br />
University of Sussex, Brighton, UK<br />
Prudence A. Francis<br />
Division of <strong>Cancer</strong> Medicine, Peter MacCallum<br />
<strong>Cancer</strong> Centre, Melbourne, AU<br />
ESO <strong>Advanced</strong> <strong>Breast</strong><br />
<strong>Cancer</strong> Task Force<br />
Eric P. Winer<br />
<strong>Breast</strong> Oncology Center,<br />
Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Joseph Gligorov<br />
Department of Medical Oncology, <strong>Cancer</strong>Est APHP<br />
Tenon, University Paris VI, Paris, FR<br />
Stella Kyriakides<br />
Europa Donna Cyprus, Nicosia, CY<br />
Nancy U. Lin<br />
<strong>Breast</strong> Oncology Center, Dana-Farber <strong>Cancer</strong><br />
Institute, Boston, US<br />
Olivia Pagani<br />
Department of Medical Oncology, Oncology<br />
Institute of Southern Switzerland, Bellinzona, CH<br />
Elzbieta Senkus-Konefka<br />
Department of Oncology and Radiotherapy, Medical<br />
University of Gdansk, Gdansk, PL<br />
Christoph Thomssen<br />
Clinic for Gynaecology, Martin-Luther-Universität,<br />
Klinikum Kröllwitz, Halle (Saale), DE<br />
8<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Coordinators:<br />
Fatima Cardoso<br />
<strong>Breast</strong> <strong>Cancer</strong> Unit,<br />
Champalimaud <strong>Cancer</strong> Center,<br />
Lisbon, PT<br />
ABC2 Patient Advocacy<br />
Committee<br />
Kathy Redmond<br />
<strong>Cancer</strong> World Magazine,<br />
Editor, Lugano, CH<br />
Dian “CJ” M. Corneliussen-James<br />
METAvivor Research and Support, Annapolis, US<br />
Susan Knox<br />
Europa Donna, Milan, IT<br />
Amelia Pinto Leite<br />
Europa Donna, Portugal, Lisbon, PT<br />
Musa Mayer<br />
<strong>Advanced</strong>BC.org, New York, US,<br />
Shirley Mertz<br />
Metastatic <strong>Breast</strong> <strong>Cancer</strong> Network US, Inverness, US<br />
Maxine Morand<br />
Australian <strong>Breast</strong> <strong>Cancer</strong> Network Victoria,<br />
Camberwell, AU<br />
Kimberly A. Sabelko<br />
Komen Foundation, Dallas, US<br />
<strong>Breast</strong> cancer patient<br />
advocacy programme<br />
Representatives of breast cancer patient<br />
advocacy groups are warmly invited to<br />
participate in ABC2 and actively contribute<br />
to the scientific programme and consensus<br />
sessions.<br />
Furthermore, in collaboration with several<br />
leading breast cancer patient advocacy groups<br />
worldwide, specific additional Meet the<br />
Expert sessions have been scheduled.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 9
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
ABC Consensus guidelines<br />
The consensus guidelines for the<br />
management of advanced breast cancer that<br />
were developed at ABC1 (November 2011) are<br />
published in The <strong>Breast</strong> 21 (2012) 242-252.<br />
The ABC1 guidelines are endorsed by SIS,<br />
the International<br />
Society of Senology<br />
(www.sisbreast.org).<br />
The ABC2 guidelines will be<br />
developed by ESO and ESMO and<br />
will be published simultaneously<br />
in Annals of Oncology and The<br />
<strong>Breast</strong>, and are endorsed by:<br />
EUSOMA<br />
FEDERACIÓN<br />
LATINOAMERICANA<br />
DE MASTOLOGIA<br />
FLAM<br />
SIS<br />
10<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Preliminary programme outline<br />
Wednesday,<br />
6 November<br />
Thursday<br />
7 November<br />
Friday<br />
8 November<br />
Saturday<br />
9 November<br />
10:00 Registration opens<br />
9:00-19:30 Exhibition 9:00-19:30 Exhibition 9:00-13:00 Exhibition<br />
9:00-10:30<br />
<strong>Breast</strong> cancer patient<br />
advocacy session<br />
9:00-10:30<br />
Satellite symposium 1<br />
9:00-10:15<br />
Inoperable locally<br />
advanced breast cancer<br />
(part I)<br />
9:00-10:30<br />
Consensus session<br />
(part I)<br />
10:15-10:45 Coffee break<br />
10:30-11:00 Coffee break 10:30-11:00 Coffee break<br />
11:00-12:30<br />
<strong>Breast</strong> cancer patient<br />
advocacy session<br />
11:00-12:30<br />
Satellite symposium 2<br />
12:30-13:30<br />
Lunch<br />
10:45-11:40<br />
Inoperable locally<br />
advanced breast cancer<br />
(part II)<br />
11:40-12:30<br />
Specific populations<br />
12:30-13:00<br />
Survivorship in advanced<br />
breast cancer:<br />
Panel discussion<br />
13:00-14:00<br />
Lunch and poster session<br />
13:30-14:15<br />
Opening session 14:00-15:40<br />
14:15-16:15<br />
Specific metastatic sites<br />
Major advances since<br />
ABC1 15:40-16:00<br />
Special session<br />
16:15-16:45 Coffee break<br />
16:45-17:30<br />
Best abstract presentations<br />
17:30-18:00<br />
ABC Award and Lecture<br />
16:00-16:30 Coffee break<br />
16:30-18:00<br />
Supportive and palliative<br />
care issues<br />
11:00-12:30<br />
Consensus session<br />
(part II)<br />
12:30-13:00<br />
Close<br />
18:00-19:30<br />
<strong>Breast</strong> cancer patient<br />
advocacy -<br />
Meet the expert session<br />
18:00-19:30<br />
Satellite symposium 3<br />
19:30 Welcome cocktail<br />
18:00-19:30<br />
<strong>Breast</strong> cancer patient<br />
advocacy -<br />
Meet the expert session<br />
18:00-19:30<br />
Satellite symposium<br />
Novartis<br />
A/V Recording during the Conference is prohibited.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 11
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Preliminary programme<br />
Wednesday, 6 November<br />
10:00 Registration opens for individual participants and groups<br />
Thursday, 7 November<br />
9:00 <strong>Breast</strong> cancer patient advocacy session<br />
9:00 Satellite symposium 1<br />
10:30 Coffee break<br />
11:00 <strong>Breast</strong> cancer patient advocacy session<br />
11:00 Satellite symposium 2<br />
12:30 Lunch<br />
13:30 Opening session (Chairs: F. Cardoso, PT and L. Norton, US)<br />
• Opening and introduction (F. Cardoso, PT)<br />
• Welcome to Lisbon (N. Cabral, President of the Port of Lisbon, PT)<br />
• Keynote lecture: A personal journal through advanced breast cancer (D. Fenech, MT)<br />
14:15 Major advances since ABC1 (Chair: E.P. Winer, US)<br />
• Advances in HER-positive advanced breast cancer (I.E. Krop, US)<br />
• Advances in TN advanced breast cancer (G.W. Sledge, US)<br />
• Advances in endocrine therapy and endocrine resistance (M.J. Piccart, BE)<br />
• Advances in cytotoxic and other targeted therapy (J. Gligorov, FR)<br />
• Advances in imaging (A.R. Padhani, UK)<br />
• Discussion<br />
16:15 Coffee break<br />
16:45 Best abstract presentations (Chair: A. Costa IT/CH)<br />
• Basic and translational research<br />
• Clinical issues<br />
• Nursing and patient advocacy<br />
17:30 ABC Award and Lecture (Awardee: J. Massagué, US)<br />
18:00 <strong>Breast</strong> cancer patient advocacy – Meet the expert session<br />
18:00 Satellite symposium 3<br />
19:30 – Welcome cocktail<br />
Friday, 8 November<br />
9:00 Inoperable locally advanced breast cancer (part I) (Chairs: F. Cardoso, PT and E.P. Winer, US)<br />
• The biology of locally advanced breast cancer: Inflammatory and non-inflammatory<br />
(F. Pernault-Llorca, FR)<br />
• Epidemiology and geographic differences (E. Senkus-Konefka, PL)<br />
• Systemic therapy: Optimal strategies and therapies (N. Harbeck, DE)<br />
• Discussion<br />
10:15 Coffee break<br />
12<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
10:45 Inoperable locally advanced breast cancer (part II) (Chairs: F. Cardoso, PT and E.P. Winer, US)<br />
• Radiotherapy: Best timing and techniques (C. Vrieling, CH)<br />
• Surgery: Challenges and opportunities (M.J. Cardoso, PT)<br />
• Discussion<br />
11:40 Specific populations (Chair: K. Gelmon, CA)<br />
• Metastatic male breast cancer (S.H. Giordano, US)<br />
• BRCA-related advanced breast cancer (P.A. Francis, AU)<br />
• Discussion<br />
12:30 Survivorship in advanced breast cancer Panel discussion (Chair: K. Redmond, CH. Panelists:<br />
P.A. Ganz, US; O. Pagani, CH; S. Kyriakides, CY; M. Mayer, US; L. Fallowfield, UK and N. West, UK)<br />
13:00 Lunch and poster session<br />
14:00 Specific metastatic sites (Chair: H.S. Rugo, US and F. André, FR)<br />
• Multidisciplinary approach to liver metastases (C.H. Barrios, BR)<br />
• Update on brain metastases management (N.U. Lin, US)<br />
• Optimal management of pleural effusions (B. Kaufman, IL)<br />
• Chest wall recurrences and cutaneous metastases (K.L. Blackwell, US)<br />
• Can specific sites of metastases be predicted and prevented? (L. van’t Veer, US)<br />
• Discussion<br />
15:40 Special session (Chair: L. Norton, US)<br />
• The role of mathematical and computer modeling for metastases research (S.D. Merajver, US)<br />
• Discussion<br />
16:00 Coffee break<br />
16:30 Supportive and palliative care issues (Chair: M.S. Aapro, CH and G.W. Sledge, US)<br />
• Optimal pain control (L. Biganzoli, IT)<br />
• Optimal management of nausea and vomiting (J. Bergh, SE)<br />
• Psycological support: When and how? (L. Fallowfield, UK)<br />
• Patient perspective on symptom control (M. Mayer, US)<br />
• Disparities in access to supportive/palliative specialised care (R.A. Badwe, IN)<br />
• Discussion<br />
18:00 <strong>Breast</strong> cancer patient advocacy - Meet the expert session<br />
18:00 – Satellite symposium Novartis<br />
19:30 <strong>Advanced</strong> breast cancer cases - Packing for the journey<br />
Saturday, 9 November<br />
9:00 Consensus session (part I)<br />
10:30 Coffee break<br />
11:00 Consensus session (part II)<br />
12:30 – Close<br />
13:00<br />
A/V Recording during the Conference is prohibited.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 13
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Consensus Panellists<br />
Matti S. Aapro, CH<br />
Fabrice André, FR<br />
Rajendra A. Badwe, IN<br />
Carlos H. Barrios, BR<br />
Jonas Bergh, SE<br />
Laura Biganzoli, IT<br />
Kimberley L. Blackwell, US<br />
David A. Cameron, UK<br />
Maria J. Cardoso, PT<br />
Tanja Cufer, SL<br />
Nagi S. El Saghir, LB<br />
Lesley Fallowfield, UK<br />
Doris Fenech, MT<br />
Prudence A. Francis, AU<br />
Patricia A. Ganz, US<br />
Karen Gelmon, CA<br />
Joseph Gligorov, FR<br />
Sharon H. Giordano, US<br />
Nadia Harbeck, DE<br />
Nehmat Houssami, AU<br />
Clifford A. Hudis, US<br />
Bella Kaufman, IL<br />
Ian E. Krop , US<br />
Stella Kyriakides, CY<br />
Nancy U. Lin, US<br />
Musa Mayer, US<br />
Sofia D. Merjaver, US<br />
Anwar R. Padhani, UK<br />
Olivia Pagani, CH<br />
Frédérique Pernault-Llorca, FR<br />
Martine J. Piccart, BE<br />
Hope S. Rugo, US<br />
Elzbieta Senkus-Konefka, PL<br />
George W. Sledge, US<br />
Christoph Thomssen, DE<br />
Laura van’t Veer, US<br />
Daniel A. Vorobiof, ZA<br />
Conny Vrieling, CH<br />
Nicola West, UK<br />
14<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Abstract submission<br />
Deadline for submission: 8 July 2013<br />
Submit on-line at<br />
www.abc-lisbon.org<br />
P<br />
articipants are invited to submit abstracts on subjects related to advanced breast<br />
cancer, including basic, translational, clinical research, nursing and advocacy.<br />
Abstracts will be assessed for presentation at the Conference, either oral or poster,<br />
or for publication only in the ABC2 Abstract Book, supplement of The <strong>Breast</strong>.<br />
Best abstracts will be selected for oral presentation within the programme with a<br />
10-minute slide presentation followed by a 5-minute discussion slot. The best abstract<br />
session is scheduled on Thursday, 7 November and the poster presentations session is<br />
scheduled on Friday, 8 November.<br />
Categories:<br />
• <strong>Advanced</strong> breast cancer - Basic and translational research<br />
• <strong>Advanced</strong> breast cancer - Nursing and advocacy<br />
• <strong>Advanced</strong> breast cancer - Clinical issues: Surgical oncology<br />
• <strong>Advanced</strong> breast cancer - Clinical issues: Radiation oncology<br />
• <strong>Advanced</strong> breast cancer - Clinical issues: Medical oncology<br />
• <strong>Advanced</strong> breast cancer - Clinical issues: Supportive and palliative care<br />
• <strong>Advanced</strong> breast cancer - Clinical issues: Else<br />
Instructions:<br />
• The number of words is limited: 50 words for the title (lower case letters) and 450<br />
words for the body of the abstract.<br />
• Names of research groups should appear in the title, not in the authors’ list.<br />
• Tables and images are not accepted.<br />
• List the authors’ affiliations. The same affiliation should be entered only once.<br />
• The first author will be the corresponding author and the presenter at the Conference.<br />
• The full address with e-mail address, phone and fax numbers of the first author<br />
(= corresponding author and presenter) must be provided. The first author will receive<br />
an acknowledgement of receipt and all subsequent communication by e-mail.<br />
• For abstracts accepted for presentation (oral or poster), the first author will be the<br />
presenting author and will be requested to register and participate in the Conference.<br />
• It is the responsibility of the first author to ascertain whether all authors are aware of<br />
the content of the abstract before submission is made.<br />
The acknowledgement of receipt of the abstract will immediately follow the submission.<br />
The outcome will be notified by 9 August to the first author who will be required to<br />
register to the conference (early registration deadline: 19 August).<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 15
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Registration<br />
Register on-line at www.abc-lisbon.org<br />
Registration grants participation in all sessions, a copy of the Programme and of the Abstract<br />
Book, coffee breaks, lunches and welcome cocktail as indicated in the programme.<br />
Regular registration<br />
Early<br />
(by 19 August 2013)<br />
Registration fee EUR 400<br />
Club ESO Members EUR 300<br />
ESMO Members EUR 300<br />
Late<br />
(by 21 October 2013)<br />
On-site<br />
(after 21 October 2013)<br />
EUR 500 EUR 650<br />
Cancellation of registration or<br />
replacement<br />
Cancellation should be notified to ESO in<br />
writing. In case of cancellation without<br />
replacement, the fee less handling charges<br />
of EUR 100 will be refunded after the event,<br />
provided that the cancellation is received by<br />
ESO before 1 October. Replacements will be<br />
possible till 1 October.<br />
Confirmation of registration<br />
Registration will be confirmed preferably by<br />
e-mail, or by fax or mail.<br />
Badge<br />
The badge is the only official evidence of<br />
registration and should be worn at all times<br />
during the event. Loss of badge causes loss of<br />
registration.<br />
Nurses and Patient Advocates<br />
Nurses and representatives of cancer patient<br />
advocacy non-profit organisations are eligible<br />
for a discounted registration fee:<br />
EUR 200 by 19 August<br />
EUR 250 by 21 October<br />
EUR 350 after 21 October and on-site<br />
To register to the Conference please e-mail<br />
the following documents to lrichetti@eso.net<br />
within the deadline:<br />
• Nurses: please provide your curriculum<br />
vitae with full contact details<br />
• Patient advocates: please provide your<br />
curriculum vitae or resume indicating<br />
your advocacy experience, role within the<br />
organisation and the full contact details of<br />
the patient advocate organisation.<br />
Media Registration<br />
The congress is open to representatives of<br />
print and electronic media. Registration<br />
is free of charge to journalists who are in<br />
possession of a valid, recognised press<br />
card. Freelance journalists must present a<br />
commissioning letter on headed paper from a<br />
recognised news organisation or publication.<br />
Representatives of advertising, marketing<br />
and public relations companies are not<br />
eligible for free media registration. A copy<br />
of the Press Card or of the commissioning<br />
letter should be sent, together with the media<br />
registration form, to lrichetti@eso.net.<br />
16<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Group registration<br />
The online group registration may be<br />
processed for groups of 5 or more individuals<br />
and will be available at www.abc-lisbon.org<br />
from April 2013.<br />
The following policy applies to the<br />
registration of groups.<br />
• Group registrations can be processed<br />
on-line only and when the number of<br />
individuals is 5 or more.<br />
• The registration fees are the same as those<br />
applied to individual registrations.<br />
• To process a registration, the participant’s full<br />
mailing address and e-mail address has to be<br />
provided within the established deadline.<br />
• Registration of participants with the same<br />
address, e-mail address, or with the address<br />
of the group leader will not be accepted.<br />
• The fee related to a cancellation will not be<br />
refunded.<br />
• The group leader will have to indicate if<br />
the on-site materials will be collected by<br />
the individual participant, or by the group<br />
Deadlines<br />
leader, or by a representative delegated for<br />
such task. The group leader will have to<br />
provide the contact details of the person<br />
who will collect the material onsite and<br />
such details will be communicated to<br />
the participants on the confirmation<br />
of registration. Please note that on-site<br />
materials (badge, delegates bag, etc.) once<br />
collected may not be re-issued.<br />
• Till 31 October 2013, when the e-mail<br />
confirmation of registration will be sent by<br />
ESO to the participants, all correspondence<br />
will be held with the group leader only.<br />
• Registration in the individual registration<br />
or in the group registration procedures<br />
grant participation in all sessions, a copy<br />
of the Programme and of the Abstract<br />
Book, coffee breaks, lunches and welcome<br />
cocktail as indicated in the programme.<br />
• As for individually registered participants,<br />
the badge is the only official evidence<br />
of registration and should be worn at all<br />
times during the event. Loss of badge<br />
causes loss of registration.<br />
Early registration fees: The group leader’s details, number of requested<br />
registrations are entered and the early registration fee is settled.<br />
Early registration fees: The full details of the participants registered with the<br />
early registration fee have to be entered.<br />
Late registration fees: New groups can be created and further registrations<br />
to existing groups can be added. By 21 October the late registration fee is<br />
to be settled and the participants’ details are to be completed. Unsettled<br />
registrations, or registrations without the complete participant’s details, are<br />
cancelled without refund.<br />
Further registrations to existing groups can be processed at the on-site<br />
registration fee and settlement is requested by on-line credit card.<br />
Name changes to existing groups can still be processed at no additional fees<br />
till 30 October.<br />
Thereafter, new registrations can be processed only on-site at the congress as<br />
individual registration.<br />
19 August<br />
2 September<br />
19 August 2013 -<br />
21 October 2013<br />
21 October 2013 -<br />
30 October 2013<br />
After 30 October 2013<br />
The confirmation of registration will be sent electronically to the participants. 31 October 2013<br />
For further information, please contact lrichetti@eso.net<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 17
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Travel grants<br />
Travel grants are made available on a<br />
competitive basis to:<br />
• Physicians from middle- and low-income<br />
countries as defined by The World Bank;<br />
• Physicians under the age of 40;<br />
• Nurses;<br />
• Patient Advocates.<br />
Full applications should be submitted by<br />
8 July 2013 to dknupfer@eso.net and include:<br />
• Curriculum vitae including full affiliation,<br />
contact details and date of birth;<br />
• Letter describing motivation for attending;<br />
• Physicians and nurses are furthermore<br />
asked to submit a letter of endorsement by<br />
the Institute/Department director or head<br />
nurse;<br />
• The successful submission of an abstract<br />
(deadline 8 July) is not mandatory but<br />
it would be considered in the selection<br />
process.<br />
Travel grant recipients will receive a<br />
set amount to contribute to their travel<br />
and accommodation expenses, whilst<br />
registration will be processed directly by<br />
ESO free of charge. The following amounts<br />
will be refunded by bank transfer after the<br />
Conference:<br />
• EUR 500 for participants coming from<br />
Europe, Middle-East and North-Africa;<br />
• EUR 1.000 for participants coming from<br />
other regions and overseas.<br />
The outcome of the application will be<br />
notified by 31 July.<br />
18<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Hotel accommodation<br />
Deadline for booking: 31 October 2013<br />
Book online at<br />
https://pco.abreu.pt/CLIENTES/abreu/formularios/form_9638101886.php<br />
or contact Helder Carvalho, Viagens Abreu SA, Linda-a-Velha, Portugal<br />
hcarvalho.lisboa@abreu.pt - ph +351 21 415 6120 - fx +351 21 415 6383<br />
Viagens Abreu has been designated as the official accommodation service for ABC2 and offers<br />
discounted rates at selected hotels.<br />
In order to secure availability and the discounted rates, participants are kindly required to<br />
proceed with their bookings by 31 October 2013.<br />
Rates are indicated in Euros and are meant per room, per night, including buffet breakfast.<br />
Payment of the stay is required to confirm the booking.<br />
Hotel<br />
Distance<br />
Km/time<br />
Public<br />
ansportation<br />
Category<br />
Single room<br />
EUR<br />
Double room<br />
EUR<br />
Altis Belém 3/15 A1 5-star 250 270<br />
Pestana Palace 0,8/8’ (walking dist) 5-star 175 190<br />
Jeronimos 8 2,5/15’ A 4-star 155 165<br />
Sofitel Lisbon Liberdade 5/20’ B 5-star 150 170<br />
Vila Gale Opera 0,3/3’ (walking dist) 4-star 135 135<br />
Tivoli Lisboa 5/20’ B 5-star 115 130<br />
Marques de Pombal 5/20’ B 4-star 102 114<br />
Tivoli Jardim 5/20’ B 4-star 105 120<br />
Sana Lisboa 6,5/25’ B 4-star 90 100<br />
Fenix Lisboa 5/20’ B 4-star 75 85<br />
Fenix Garden 5/20’ B 3-star 65 75<br />
Booking cancellation:<br />
Cancellations should be notified in writing to Helder Carvalho, Viagens Abreu.<br />
Until 2 August<br />
fully refunded less EUR 25 as administrative fees<br />
Until 15 September 50% will be refunded<br />
Until 15 October 25% will be refunded<br />
From 16 October no refund<br />
No-shows<br />
no refund<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 19
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Public transportation:<br />
A1 Walk 700 meters from the Hotel to Tram/Bus stop<br />
Tram 15 Belem Praça do Comercio (city centre)<br />
or Bus 28 Belem Praça do Comercio (city centre)<br />
A Tram 15 Belem Praça do Comercio (city centre)<br />
or Bus 28 Belem Praça do Comercio (city centre)<br />
B<br />
From hotel to venue:<br />
Bus 732 Praça do Comercio (city centre) Avenida da Liberdade (1)<br />
Avenida Fontes Pereira de Melo (2)<br />
1: Tivoli Lisboa, Sofitel Lisbon Liberdade, Marques de<br />
Pombal, Tivoli Jardim, Fenix Lisboa, Fenix Garden<br />
2: Sana Lisboa<br />
then Tram 15 Belem Praça do Comercio (city centre)<br />
or Bus 28 Belem Praça do Comercio (city centre)<br />
The stop at the Congress Centre is called «Rua Junqueira»<br />
Hotels map<br />
20<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Optional tours<br />
Viagens Abreu offers a selection of optional tours. Tours will be operated with a minimum of 20<br />
participants.<br />
All tours will depart and return to the Lisboa Congress Centre in air conditioned buses with an<br />
official English speaking guide.<br />
Book online at: https://pco.abreu.pt/CLIENTES/abreu/formularios/form_9638101886.php<br />
Half-day tour to Lisbon<br />
Wednesday, 6 November,<br />
14:00-18:00 hours<br />
Rate: EUR 39 per person<br />
Visit this remarkable City, with its near 2.500<br />
years of history, and its downtown and historical<br />
districts. Highlights of this tour include the<br />
12th century fortress of St. George’s, located<br />
on top of one of Lisbon’s seven hills, and overlooking<br />
the whole downtown and river Tagus<br />
and the former Moorish quarter of Alfama,<br />
where still exist buildings that have survived<br />
the 1755 big earthquake.<br />
Then, west of Lisbon, visit the historical<br />
Belém, home of the shipyards where in the<br />
15th century were built the Portuguese Caravelas<br />
(sailing boats) and from where expeditions<br />
departed to find the maritime routes to<br />
Africa, Asia and Brazil, in glorious sea adventures<br />
that have compared the Portuguese navigators<br />
wiith the American first astronauts.<br />
In Belém, will visit the Jerónimos Monastery, a<br />
master piece of the manueline style, and stop<br />
by the famous landmarks: Belém Tower and<br />
the Monument to the Discoveries.<br />
Entrance fee at St. George’s Castle is included.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 21
<strong>Advanced</strong> <strong>Breast</strong> <strong>Cancer</strong> Second International Consensus Conference<br />
Half-day tour of Sintra<br />
Wednesday, 6 November, 14:00-18:00 hours or<br />
Saturday, 9 November, 14:00-18:00 hours<br />
Rate: EUR 39 per person<br />
Sintra, located NW of Lisbon, is a delightful small<br />
town, full of historical sites whose roots go back to<br />
the Arab occupation in the 12th century.<br />
Later on, Sintra was a summer retreat for the Portuguese<br />
Royal families and Nobels, and due to its romantic<br />
setting, it was immortalized by the British<br />
poet Lord Byron, as the «Little Eden».<br />
Our tour will visit its historical centre and the National<br />
Palace, built over a former Moorish palace. From this<br />
area, one can admire the many manor houses and see<br />
the medieval castle built up on top of the mountain.<br />
Then the tour will continue around this beautiful<br />
montain, reaching a totally different environment –<br />
the wild and beautiful coast line of Guincho, with its<br />
superb beach areas, cliffs and where, close by, is located<br />
Cape Roca, the westernmost point of continental<br />
Europe.<br />
The tour will return to Lisbon, via Cascais, a cosmopolitan<br />
former fishing village, and the Estoril coast<br />
line.<br />
Entrance fee at the Sintra National Palace is included.<br />
22<br />
ABC2 7-9 NOVEMBER 2013, LISBON, PORTUGAL
Half day tour to<br />
Óbidos and Fátima<br />
Saturday, 9 November,<br />
14:00-18:00 hours<br />
Rate: EUR 53 per person<br />
The first stop will be one of Portugal’s well kept secret<br />
– the Medieval walled town of Óbidos. Nestled<br />
inside a 12th century fortress, with its white washed<br />
well preserved houses, the town of Óbidos has kept<br />
its traditions, monuments and well kept cobblestone<br />
streets, allowing visitors a enjoyable walk through,<br />
and exploring not just the town and its walled fortification,<br />
but also its small churches, small shops and<br />
original bars.<br />
The famous «Ginginha» served on a chocolate made<br />
cup is probably its best drink.<br />
From Óbidos, we will proceed towards the famous<br />
Fátima pilgrimage site. Famous for its Roman Catholic<br />
Shrine and Basilica, Fátima is recognized by the<br />
Vatican as a site where the Virgin was seen by three<br />
shepherd children, on the 13th day of six consecutive<br />
months from May to October in 1917.<br />
7-9 NOVEMBER 2013, LISBON, PORTUGAL ABC2 23
European School of Oncology<br />
Your Education<br />
live, free and just a click<br />
away!<br />
e-ESO sessions<br />
weekly e-grandrounds<br />
and monthly e-oncoreviews<br />
www.e-eso.net<br />
Connect<br />
every Thursday of each week<br />
1st Tuesday of each month<br />
18:15 CET<br />
Learn<br />
with our experts and<br />
discussants<br />
Interact<br />
make your questions and<br />
receive live answers<br />
Access<br />
at any time, to any past<br />
recorded session<br />
(available for 6 months)<br />
Get<br />
CME and ESMO-MORA<br />
credits<br />
Play<br />
mastermind participant<br />
quiz<br />
JOIN LIVE AND INTERACT<br />
9:15 SAN FRANCISCO<br />
12:15 BOSTON, NEW YORK<br />
17:15 LONDON, DUBLIN, LISBON<br />
18:15 BRUSSELS, PARIS, MADRID,<br />
MILAN, JOHANNESBURG<br />
19:15 ATHENS, TEL AVIV, CAIRO<br />
20:15 MOSCOW<br />
21:45 MUMBAI<br />
Your weekly/monthly appointment with education<br />
organised without commercial sponsorship by the<br />
European School of Oncology in collaboration with
Notes<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
..............................................................................................................................................................................................................................................................<br />
25
REGISTRATION FORM<br />
ABC2 – 7-9 November 2013, Lisbon, Portugal<br />
Please fill in this form in block capitals and send by the deadline to:<br />
European School of Oncology, ESO Bellinzona Office, Attn. Laura Richetti<br />
Piazza Indipendenza 2 – 6500 Bellinzona, Switzerland – Fax +41 91 820 0953 – lrichetti@eso.net<br />
Online registration is available at www.abc-lisbon.org<br />
Participant’s details<br />
Dr. Prof.<br />
Surname<br />
Institute<br />
Name<br />
Department<br />
Street<br />
Zip code Town Country<br />
Phone Fax Mobile<br />
e-mail<br />
Profession<br />
Specialisation<br />
Main field<br />
VAT number (compulsory for self-employed persons)<br />
Fiscal code (Italian residents only)<br />
If your invoice details are different to those above, please complete the following section:<br />
Invoice contact person<br />
Address<br />
Phone<br />
e-mail<br />
VAT number (compulsory for companies or self-employed persons)<br />
Fiscal code (Italian residents only)<br />
Payable in Euro<br />
Early<br />
(by 19 August 2013)<br />
Late<br />
(by 21 October 2013)<br />
Registration fee EUR 400<br />
Club ESO Members<br />
ESMO Members<br />
EUR 300<br />
EUR 500<br />
Payment details<br />
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)<br />
Visa/Mastercard<br />
Number<br />
Expiry date<br />
CV2 code<br />
Holder’s name:<br />
and signature<br />
Bank transfer with no cost to the beneficiary (please provide a copy of the bank transfer):<br />
Bank<br />
Banca Popolare di Milano, Agenzia 24, Milano, Italy<br />
Holder<br />
European School of Oncology<br />
Number 16333<br />
IBAN IT96G0558401624 0000000 16333<br />
BIC<br />
BPMIITM1024<br />
Reference «ABC2 + your name»<br />
I authorise the European School of Oncology to use my personal data according to what is specified in Article 13 DLGS<br />
196, available at www.eso.net or on request at fax number +39 02 8546 4545.<br />
Signature<br />
Date
It’s easy to save money on your flights if you fly the Star Alliance<br />
network. Simply quote the event code TP01S13 when you make your<br />
booking with any Star Alliance member airline and you’ll automatically<br />
get a discount of up to 20%.<br />
The Star Alliance network has 27 member airlines with over 21,555<br />
flights a day so we can offer you a lot more choice when planning your<br />
travel. For more information about our member airlines and contact<br />
details, please visit our website at staralliance.com/conventionsplus<br />
staralliance.com<br />
Information correct as at 06/2012
European School of Oncology<br />
Via Turati 29<br />
20121 Milano, Italy<br />
ph +39 02 85464 532 fx +39 02 85464 545<br />
www.abc-lisbon.org www.eso.net<br />
European School of Oncology<br />
Piazza Indipendenza 2<br />
6500 Bellinzona, Switzeland<br />
ph +41 91 820 0950 fx +41 91 820 0953<br />
www.abc-lisbon.org www.eso.net<br />
is member of
Change language